Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.220
-0.030 (-2.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Atai Life Sciences N.V.
< Previous
1
2
3
4
Next >
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
August 13, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 07, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
June 26, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
June 20, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
May 23, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
May 15, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
April 24, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
April 17, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
March 28, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
March 27, 2024
From
atai Life Sciences
Via
GlobeNewswire
The Next Great Biotech Boom Has Arrived
March 19, 2024
EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
March 04, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
February 06, 2024
From
atai Life Sciences
Via
GlobeNewswire
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
January 24, 2024
EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
January 04, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
January 02, 2024
From
atai Life Sciences
Via
GlobeNewswire
5 Biotech stocks tapping into unmet mental health treatment needs
December 20, 2023
Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.
Via
MarketBeat
atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
November 14, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
October 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
October 02, 2023
From
atai Life Sciences
Via
GlobeNewswire
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
September 19, 2023
EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Exposures
Economy
Product Safety
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 14, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in Upcoming September Investor Conferences
September 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
August 10, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
August 08, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in Upcoming June Investor Conferences
June 01, 2023
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
May 11, 2023
From
atai Life Sciences
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.